S100B and early-onset autosomal dominant Alzheimer disease: High levels of S100B are characteristic of Down Syndrome, Alzheimer’s disease, Creutzfeldt–Jakob disease, schizophrenia, multiple sclerosis, brain tumors, epilepsy, melanoma, myocardial infarction, muscle disorders, and sarcopenia [4,5,6].